Whole-brain radiotherapy in patients with brain metastases from melanoma

av de la Fuente, Macarena, Beal, Kathryn, Carvajal, Richard, Kaley, Thomas J
I publikationen CNS Oncol (2014)

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab

av Thomas, Alissa, Rosenblum, Marc, Karimi, Sasan, DeAngelis, Lisa M, Omuro, Antonio, Kaley, Thomas J
I publikationen CNS Oncol (2018)

Bevacizumab in high-grade glioma patients following intraparenchymal hemorrhage

av Lin, Xuling, Daras, Mariza, Pentsova, Elena, Nolan, Craig P., Gavrilovic, Igor T., DeAngelis, Lisa M., Kaley, Thomas J.
I publikationen Neurooncol Pract (2017)

Phase I Study of RO4929097 with Bevacizumab in Patients with Recurrent Malignant Glioma

av Pan, Edward, Supko, Jeffrey G., Kaley, Thomas J., Butowski, Nicholas A., Cloughesy, Timothy, Jung, Jinkyu, Desideri, Serena, Grossman, Stuart, Ye, Xiaobu, Park, Deric M.
I publikationen J Neurooncol (2016)

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

av Kaley, Thomas J., Panageas, Katherine S., Mellinghoff, Ingo K., Nolan, Craig, Gavrilovic, Igor T., DeAngelis, Lisa M., Abrey, Lauren E., Holland, Eric C., Lassman, Andrew B.
I publikationen J Neurooncol (2019)

Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma

av Schram, Alison M., Jonsson, Philip, Drilon, Alexander, Bale, Tejus A., Hechtman, Jaclyn F., Benayed, Ryma, Hanusch, Bethany, Young, Robert J., Grommes, Christian, Ku, Nora, Kaley, Thomas J., Hyman, David M., Taylor, Barry S.
I publikationen JCO Precis Oncol (2018)

A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma

av Gerstner, Elizabeth R., Ye, Xiaobu, Duda, Dan G., Levine, Michael A., Mikkelsen, Tom, Kaley, Thomas J., Olson, Jeffrey J., Nabors, Burt L., Ahluwalia, Manmeet S., Wen, Patrick Y., Jain, Rakesh K., Batchelor, Tracy T., Grossman, Stuart
I publikationen Neuro Oncol (2015)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

av Kaley, Thomas J., Panageas, Katherine S., Pentsova, Elena I., Mellinghoff, Ingo K., Nolan, Craig, Gavrilovic, Igor, DeAngelis, Lisa M., Abrey, Lauren E., Holland, Eric C., Omuro, Antonio, Lacouture, Mario E., Ludwig, Emmy, Lassman, Andrew B.
I publikationen Ann Clin Transl Neurol (2020)

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

av Omuro, Antonio, Correa, Denise D., DeAngelis, Lisa M., Moskowitz, Craig H., Matasar, Matthew J., Kaley, Thomas J., Gavrilovic, Igor T., Nolan, Craig, Pentsova, Elena, Grommes, Christian C., Panageas, Katherine S., Baser, Raymond E., Faivre, Geraldine, Abrey, Lauren E., Sauter, Craig S.
I publikationen Blood (2015)

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

av Omuro, Antonio, Chan, Timothy A., Abrey, Lauren E., Khasraw, Mustafa, Reiner, Anne S., Kaley, Thomas J., DeAngelis, Lisa M., Lassman, Andrew B., Nolan, Craig P., Gavrilovic, Igor T., Hormigo, Adilia, Salvant, Cynthia, Heguy, Adriana, Kaufman, Andrew, Huse, Jason T., Panageas, Katherine S., Hottinger, Andreas F., Mellinghoff, Ingo
Publicerad 2013

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

av Kaley, Thomas J., Wen, Patrick, Schiff, David, Ligon, Keith, Haidar, Sam, Karimi, Sasan, Lassman, Andrew B., Nolan, Craig P., DeAngelis, Lisa M., Gavrilovic, Igor, Norden, Andrew, Drappatz, Jan, Lee, Eudocia Quant, Purow, Benjamin, Plotkin, Scott R., Batchelor, Tracy, Abrey, Lauren E., Omuro, Antonio
I publikationen Neuro Oncol (2015)

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

av Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
I publikationen Blood (2019)

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

av Norden, Andrew D., Ligon, Keith L., Hammond, Samantha N., Muzikansky, Alona, Reardon, David A., Kaley, Thomas J., Batchelor, Tracy T., Plotkin, Scott R., Raizer, Jeffrey J., Wong, Eric T., Drappatz, Jan, Lesser, Glenn J., Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q., Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C., Gerard, Mary, Smith, Katrina H., McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y.
I publikationen Neurology (2015)

Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

av Omuro, Antonio, Beal, Kathryn, Gutin, Philip, Karimi, Sasan, Correa, Denise D., Kaley, Thomas J., DeAngelis, Lisa M., Chan, Timothy A., Gavrilovic, Igor T., Nolan, Craig, Hormigo, Adilia, Lassman, Andrew B., Mellinghoff, Ingo, Grommes, Christian, Reiner, Anne S., Panageas, Katherine S., Baser, Raymond E., Tabar, Viviane, Pentsova, Elena, Sanchez, Juan, Barradas-Panchal, Renata, Zhang, Jianan, Faivre, Geraldine, Brennan, Cameron W., Abrey, Lauren E., Huse, Jason T.
I publikationen Clin Cancer Res (2014)

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

av Lee, Eudocia Q., Kaley, Thomas J., Duda, Dan G., Schiff, David, Lassman, Andrew B., Wong, Eric T., Mikkelsen, Tom, Purow, Benjamin W., Muzikansky, Alona, Ancukiewicz, Marek, Huse, Jason T., Ramkissoon, Shakti, Drappatz, Jan, Norden, Andrew D., Beroukhim, Rameen, Weiss, Stephanie E., Alexander, Brian M., McCluskey, Christine S., Gerard, Mary, Smith, Katrina H., Jain, Rakesh K., Batchelor, Tracy T., Ligon, Keith L., Wen, Patrick Y.
I publikationen Clin Cancer Res (2015)

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

av Omuro, Antonio, Beal, Kathryn, McNeill, Katharine, Young, Robert J., Thomas, Alissa, Lin, Xuling, Terziev, Robert, Kaley, Thomas J., DeAngelis, Lisa M., Daras, Mariza, Gavrilovic, Igor T., Mellinghoff, Ingo, Diamond, Eli L., McKeown, Andrew, Manne, Malbora, Caterfino, Andrew, Patel, Krishna, Bavisotto, Linda, Gorman, Greg, Lamson, Michael, Gutin, Philip, Tabar, Viviane, Chakravarty, Debyani, Chan, Timothy A., Brennan, Cameron W., Garrett-Mayer, Elizabeth, Karmali, Rashida A., Pentsova, Elena
I publikationen J Clin Oncol (2018)

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

av de la Fuente, Macarena I., Young, Robert J., Rubel, Jennifer, Rosenblum, Marc, Tisnado, Jamie, Briggs, Samuel, Arevalo-Perez, Julio, Cross, Justin R., Campos, Carl, Straley, Kimberly, Zhu, Dongwei, Dong, Chuanhui, Thomas, Alissa, Omuro, Antonio A., Nolan, Craig P., Pentsova, Elena, Kaley, Thomas J., Oh, Jung H., Noeske, Ralph, Maher, Elizabeth, Choi, Changho, Gutin, Philip H., Holodny, Andrei I., Yen, Katharine, DeAngelis, Lisa M., Mellinghoff, Ingo K., Thakur, Sunitha B.
I publikationen Neuro Oncol (2016)

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

av Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.
I publikationen Nat Med (2019)

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

av Grommes, Christian, Pastore, Alessandro, Palaskas, Nicolaos, Tang, Sarah S., Campos, Carl, Schartz, Derrek, Codega, Paolo, Nichol, Donna, Clark, Owen, Hsieh, Wan-Ying, Rohle, Dan, Rosenblum, Marc, Viale, Agnes, Tabar, Viviane S, Brennan, Cameron W, Gavrilovic, Igor T., Kaley, Thomas J, Nolan, Craig P, Omuro, Antonio, Pentsova, Elena, Thomas, Alissa A, Tsyvkin, Elina, Noy, Ariela, Palomba, M. Lia, Hamlin, Paul, Sauter, Craig S., Moskowitz, Craig H., Wolfe, Julia, Dogan, Ahmet, Won, Minhee, Glass, Jon, Peak, Scott, Lallana, Enrico C, Hatzoglou, Vaios, Reiner, Anne S, Gutin, Philip H, Huse, Jason T, Panageas, Katherine S, Graeber, Thomas G, Schultz, Nikolaus, DeAngelis, Lisa M, Mellinghoff, Ingo K
I publikationen Cancer Discov (2017)

Genomic correlates of disease progression and treatment response in prospectively characterized gliomas

av Jonsson, Philip, Lin, Andrew L., Young, Robert J., DiStefano, Natalie M., Hyman, David M., Li, Bob T., Berger, Michael F., Zehir, Ahmet, Ladanyi, Marc, Solit, David B., Arnold, Angela G., Stadler, Zsofia K., Mandelker, Diana, Goldberg, Michael E., Chmielecki, Juliann, Pourmaleki, Maryam, Ogilvie, Shahiba Q., Chavan, Shweta S., McKeown, Andrew T., Manne, Malbora, Hyde, Allison, Beal, Kathryn, Yang, T. Jonathan, Nolan, Craig P., Pentsova, Elena, Omuro, Antonio, Gavrilovic, Igor T., Kaley, Thomas J., Diamond, Eli L., Stone, Jacqueline B., Grommes, Christian, Boire, Adrienne, Daras, Mariza, Piotrowski, Anna F., Miller, Alexandra M., Gutin, Philip H., Chan, Timothy A., Tabar, Viviane S., Brennan, Cameron W., Rosenblum, Marc, DeAngelis, Lisa M., Mellinghoff, Ingo K., Taylor, Barry S.
I publikationen Clin Cancer Res (2019)